Sen, Triparna <br/><br/>
Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231.  [electronic resource] 

 -  Anti-cancer drugs  Jul 2010 
 - 632-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/cad.0b013e32833a4385  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticarcinogenic Agents--pharmacology<br/>Breast Neoplasms--enzymology<br/>Carrier Proteins--antagonists & inhibitors<br/>Catechin--analogs & derivatives<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Survival--drug effects<br/>Down-Regulation--drug effects<br/>Extracellular Matrix Proteins--metabolism<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Female<br/>Focal Adhesion Protein-Tyrosine Kinases--metabolism<br/>Humans<br/>Matrix Metalloproteinase 9--metabolism<br/>NF-kappa B--metabolism<br/>RNA, Messenger--metabolism<br/>Signal Transduction--drug effects<br/>Tissue Inhibitor of Metalloproteinase-1--metabolism<br/>Transcription Factor AP-1--metabolism